D in Europe

At one time the scene of most of the world's great scientific discoveries, Europe still has a formidable reputation in fields such as particle physics and molecular biology. Yet growing concern about a "technology gap" with the United States and Japan has provided one of the motives for the European Economic Community Framework Program of Research and Technological Development, whose budget for 1987-91 has been the subject of intense political debate in recent months. The United Kingdom, while e

Written byBernard Dixon
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

As director-general of the Commission's Directorate-General for Science, Research and Development, Paolo Fasella is fighting to ensure the future of European collaborative research on the scale enshrined in the Framework program. Fasella, past president of the International Union of Biological Science, also sits on the councils of the European Molecular Biology Laboratory and the European Science Foundation. A 1954 graduate of the medical school at the University of Rome, he has been a professor of biochemistry at the University of Rome since 1971. He was interviewed in Brussels on May 13 by Bernard Dixon, European editor of The Scientist. This is an edited version of their talk.

The greater value of science today means it has become more important to the EEC— which, after all, is an economic organization. It also stems from the blurring of the distinction between science and technology. While technology is more dependent upon science these ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies